INS and Hyperglycemia: Proportion of children and adolescents with DKA at clinical diagnosis.*Median HbA1c at clinical diagnosis (stage 3).*Per cent of children and adolescents with symptoms at clinical diagnosis (stage 3).*Median kg weight loss at clinical diagnosis (stage 3).*Days of hospitalisation at clinical diagnosis (including days at ICU).*Random or fasting C-peptide during oral glucose tolerance test at clinical diagnosis.*Insulin requirement at clinical diagnosis stabilising hyperglycaemia.*